Accéder au contenu
Merck

MAO inhibitors: risks, benefits, and lore.

Cleveland Clinic journal of medicine (2010-12-15)
Molly Wimbiscus, Olga Kostenko, Donald Malone
RÉSUMÉ

Monoamine oxidase (MAO) inhibitors were the first antidepressants introduced, but their use has dwindled because of their reported side effects, their food and drug interactions, and the introduction of other classes of agents. However, interest in MAO inhibitors is reviving. Here, we discuss their use, risks, and benefits in clinical medicine.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Monoamine Oxidase Insect Cell Control, recombinant, expressed in wild-type baculovirus infected BTI insect cells